Health Condition 1: null- Severe pregnancy induced hypertension
Conditions
Interventions
Intervention1: Intravenous hydralazine: 5mg as a slow bolus dose administered intravenously and repeated 10mg every 20-minutes until the desired effect was achieved up to a maximum of 5 doses
Control
Sponsors
College of Medicine and JNM Hospital West Bengal University of Health Sciences Kalyani
Eligibility
Inclusion criteria
Inclusion criteria: Pregnancy more than 20weeks and Severe Pregnancy Induced Hypertension (systolic blood pressure of 160mmHg or more and /or diastolic blood pressure of 110mmHg or more)
Exclusion criteria
Exclusion criteria: Pregnancy beyond less than 20 weeks gestational age Who do not agree for consent. Contraindication or known allergy to hydralazine or labetalol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study is expected to conclude the adverse effect in pregnancy in terms of maternal and fetal outcome. Maternal outcomes are of two types immediate and long term. Expected immediate outcomes will likely differences in blood pressure.Timepoint: 30 minutes after administration of drugs and in every 30 minutes thereafter till termination of pregnancy | — |
Secondary
| Measure | Time frame |
|---|---|
| -Quality of life -Cost effectiveness -Treatment failure rateTimepoint: 30 minutes after administration of drugs and in every 30 minutes thereafter till termination of pregnancy | — |
Countries
India
Contacts
Public ContactDr Mriganka Mouli Saha
College of Medicine and JNM Hospital, West Bengal University of Health Sciences, Kalyani
Outcome results
None listed